Residual disease is the main, but not the only factor impacting satisfaction in psoriatic patients undergoing biological therapies
Giacomo Caldarola(Università Cattolica del Sacro Cuore), Clara De Simone(IRCCS San Camillo Hospital), Enrico Bocchino(Università Cattolica del Sacro Cuore), Eleonora De Luca(Università Cattolica del Sacro Cuore), Ketty Peris(Università Cattolica del Sacro Cuore), Lucia Di Nardo(Università Cattolica del Sacro Cuore), Magda D’Agostino(Università Cattolica del Sacro Cuore), Gennaro Marco Falco(Università Cattolica del Sacro Cuore)
Cited by 3
Related Papers
Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
|European Journal of Cancer|2019|589
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment
|European Journal of Cancer|2020|324
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022
|European Journal of Cancer|2022|320
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022
|European Journal of Cancer|2022|287
Understanding the Molecular Genetics of Basal Cell Carcinoma
|International Journal of Molecular Sciences|2017|243